The Coronavirus Disease 2019 Pandemic and Time to Diagnosis for Childhood Pulmonary Diseases: Outcomes of a Tertiary Care Center
Authors:
- Meltem Akgül ErdalMEMeltem Akgül Erdal
- Halime Nayır BüyükşahinHBHalime Nayır Büyükşahin
- İsMail GüzelkaşIGİsMail Güzelkaş
- Birce SunmanBSBirce Sunman
- Didem AlboğaDADidem Alboğa
- Nagehan EmiralioğluNENagehan Emiralioğlu
- Ebru YalçınEYEbru Yalçın
- Deniz DoğruDDDeniz Doğru
- H. Uğur ÖzçelikHÖH. Uğur Özçelik
- Nural KiperNKNural Kiper
Open Access
- 1 July 2024
- journal article
- research article
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (4) , 370-374
Abstract
Objectives: Coronavirus disease 2019 pandemic caused many changes in the social behaviors of individuals and the provision of health systems. Many studies revealed reductions in the number of diagnoses and delays in diagnosis time during the pandemic. This study aimed to evaluate the effect of the pandemic on the time to diagnosis of major diseases of pediatric pulmonology. Materials and Methods: Newly diagnosed patients with cystic fibrosis (CF), childhood interstitial lung disease (chILD), tuberculosis (TB), and primary ciliary dyskinesia (PCD) were grouped into pandemic (group 1) and 2 consecutive pre-pandemic periods divided into equal intervals (groups 2 and 3). For each disease group, the time to diagnosis was compared between the specified periods. Results: A total number of patients were 171 in this study. In the CF group, there was no statistically difference in time to diagnosis between periods. In the chILD group, there was a statistically significant difference in time to diagnosis (P = .036) between groups (group 1: 2 months, group 2: 4 months and group 3: 10.5 months) that was not originated from pandemic period. In TB group there was no statistically significant difference between groups. In the PCD group, the impact of the pandemic on the time to diagnosis could not be clarified because the time interval to diagnosis (minimum: 2 years, maximum: 16 years) exceeded the studied periods (21 months). Conclusion: In our study, no effect found between the pandemic and age at diagnosis or time to diagnosis in patients with PCD, chILD, CF, and TB at our center. Cite this article as: Akgül Erdal M, Nayır Büyükşahin H, Güzelkaş İ, et al. The coronavirus disease 2019 pandemic and time to diagnosis for childhood pulmonary diseases: Outcomes of a tertiary care center. Turk Arch Pediatr. 2024;59(4):370-374.Keywords
This publication has 20 references indexed in Scilit:
- Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic ReviewJCO Global Oncology, 2021
- Delayed presentation and sub-optimal outcomes of pediatric patients with acute appendicitis during the COVID-19 pandemicJournal of Pediatric Surgery, 2021
- Effect of COVID-19 pandemic process on prenatal diagnostic proceduresThe Journal of Maternal-Fetal & Neonatal Medicine, 2020
- Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and IrelandArchives of Disease in Childhood, 2020
- The past and future of genetics in pulmonary disease: You can teach an old dog new tricksPediatric Pulmonology, 2020
- Delayed access or provision of care in Italy resulting from fear of COVID-19The Lancet Child & Adolescent Health, 2020
- The genetics of interstitial lung diseasesEuropean Respiratory Review, 2019
- Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenClinical Infectious Diseases, 2017
- European protocols for the diagnosis and initial treatment of interstitial lung disease in childrenThorax, 2015